The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry. Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications.

The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Next-Generation Sequencing market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities.

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/8

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Next-Generation Sequencing market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

Illumina, Inc., BGI Group, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Hamilton Company, Macrogen, Lucigen, Partek Incorporated, Intrexon Bioinformatics GmbH, and DNASTAR.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market

Emergen Research has segmented the global Next-Generation Sequencing market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

• Technology Outlook (Revenue, USD Billion; 2017-2027)

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

• Workflow Outlook (Revenue, USD Billion; 2017-2027)

  • Pre-sequencing
  • Sequencing
  • NGS Data Analysis

• Application Outlook (Revenue, USD Billion; 2017-2027)

  • Clinical Investigation
  • Oncology
  • Reproductive Health
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Agrigenomics & Forensics
  • Consumer Genomics

The various regions analyzed in the report include:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

• Analysis and estimation of the Next-Generation Sequencing Market size and share for the projected period of 2022-2030
• Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
• Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Next-Generation Sequencing Market
• Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
• Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/8

Latest Published Reports by Emergen Research:

https://www.emergenresearch.com/industry-report/biosolids-market

https://www.emergenresearch.com/industry-report/bone-allografts-market

https://www.emergenresearch.com/industry-report/bone-morphogenetic-proteins-market

https://www.emergenresearch.com/industry-report/bovine-tuberculosis-diagnosis-market

 About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Nanoceramics Powder Market | Minimal Residual Disease Testing Market

Latest Report:  Molecular Sieves Market | Microfluidics Prototype Market